Regulatory Affairs Consultant

Specialized regulatory services across pharmaceuticals, medical devices, quasi-drugs, cosmetics, health foods, veterinary products, industrial and consumer goods.

Cisema is your trusted regulatory affairs consultant for China, Hong Kong, Taiwan, South Korea and Southeast Asia. With significant regulatory experience, we deliver customized regulatory strategy, authority communication, and full lifecycle management tailored to your product type and regulatory challenge. Whether launching drug applications, registering a medical device, or filing a cosmetic or health supplement, our regulatory affairs experts provide hands on support from submission to surveillance, ensuring successful market entry in key markets.

Market Access Consulting
Regulatory Affairs Consultant
Medical device clinical trial in China img

Regulatory Intelligence

In today’s fast-paced regulatory landscape, we keep our clients ahead by delivering timely regulatory intelligence. We continuously monitor and analyze regulatory changes, updates, and trends from regulatory agencies and regulatory authorities not only in the jurisdictions we specialize in but also worldwide. With our deep understanding of both global regulatory requirements and local requirements, we provide actionable insights that help companies anticipate potential challenges, adapt strategies, and maintain compliance. By taking this proactive approach, we not only support the development of effective regulatory strategies but also maximize approval success and minimize costly delays, ensuring our clients maintain a competitive edge.

Regulatory consulting

Pharmaceutical & Biotech Regulatory Services

The Asia Pacific region offers major opportunities for life sciences companies, but success requires more than global documentation. At Cisema, we provide tailored regulatory affairs consulting that combines regulatory intelligence, local expertise, and operational precision. From clinical trial applications to post-market lifecycle management, our experienced team reduces approval risks, ensures compliance with local requirements, and streamlines regulatory submissions to accelerate successful market entry across the region.

Regulatory Strategy & Planning

Regulatory classification and country-specific roadmap development
Local adaptation of global regulatory strategy
(Pre-) IND,s CTAs, (Pre-) NDAs, MAAs, BLAs, to DMF planning and submissions

Dossier Preparation & Submission Management

Full lifecycle document preparation and formatting
Submission management to NMPA and APAC authorities
Real-time engagement for regulatory submissions

CMC & GMP Support

Gap analysis and CMC documentation preparation
GMP readiness assessment and strategic support
Technology transfer and compliance alignment

Labeling & Promotional Compliance

Regulatory review of labeling and advertising
Language adaptation and warning statements
Compliance with promotional material guidelines

Local Representation

NMPA Legal Agent services
Liaison with regulatory agencies and domestic communications
Regulatory Consultants for Marketing Authorizations

Medical Device & IVD Regulatory Services

As a medical device regulatory affairs consultant, we help manufacturers align with regulatory requirements, achieve product approvals, and stay compliant throughout the regulatory pathway.

Product Registration & Classification

Device classification and advice on the best pathway to market
Registration documentation preparation
Country-specific registrations

Testing & Clinical Requirements

NMPA type testing with on-site engineer supervision
Clinical trials and clinical evaluations setup and management when required
Clinical Evaluation Report (CER) preparation

Combination Products

Pathway development for drug-device combinations
Determining lead component and regulatory submissions
Coordinated handling with regulatory authorities

Quality Compliance & PMS

Pre-inspection readiness support
Post-Market Surveillance (PMS) programs
Adverse event monitoring and reporting

Local Legal Representation

Legal Agent and Local Responsible Person in various jurisdictions throughout Asia Pacific including China, Hong Kong and Taiwan

Quasi-Drug Products

As a regulatory consultant and License Holder in South Korea, we assess your product category, identify the correct MFDS pathway, prepare the required documentation, and support communication with Korean authorities and relevant import bodies.

Regulatory Strategy & Classification

Determine whether your product is regulated as a quasi-drug, cosmetic, hygiene product, medical device, or pharmaceutical in Korea

Dossier Preparation & Submission

Prepare and submit quasi-drug notifications and approval applications
Manage MFDS communications, supplementary responses, and application follow-up

Korea License Holder

Local authorized representative
Liaison with regulatory authorities
Support adverse event reporting and regulatory notifications
Regulatory excellence for cosmetics companies

Cosmetic Regulatory Services

As a cosmetic regulatory affairs consultant, we help companies ensure compliance with regulatory requirements in both China and Taiwan.

Product Filing & Registration

China NMPA general and special cosmetic filing
Taiwan TFDA notification and unified system submissions
New cosmetic ingredient registration and CIC filings

Responsible Person Representation

Appointed RP for China and Taiwan
Certificate management and regulatory submissions

Labeling, Packaging, & Claims Review

INCI verification and efficacy claims review
Taiwan and China label compliance
Fair packaging checks

Cosmetic Testing & GMP Compliance

Microbiological, chemical, toxicological, and efficacy testing
Cosmetic GMP audits and QMS alignment
SOP drafting and documentation preparation

Post-Market Surveillance & Cosmetovigilance

Adverse event monitoring and risk classification
Reporting system setup and trend analysis
Health Food Regulatory Consultants

Health Food & Supplement Regulatory Services

We act as a health food regulatory affairs consultant, supporting product development and helping companies achieve market access while meeting regulatory requirements.

Regulatory Classification & Filing

Product classification (health food, functional food, general food)
Health food registration and notification
Functional claim verification

Label & Ingredient Compliance

Ingredient and formula review against IECIC
Functional claims catalogue checks
Label validation and country-of-origin declaration

Safety & Functional Testing

Nutrient verification
Toxicological and efficacy testing
Approved lab studies for product development

Responsible Agent & 
Post-Market Compliance

Legal agent services for health food
Ongoing compliance and surveillance support
Regulatory affairs consultant

Veterinary Medicines & Products

As a veterinary regulatory affairs consultant, we offer regulatory expertise for MARA and NMPA submissions to support marketing authorization of veterinary products.

Product Registration & Classification

Veterinary medicine registration with MARA
Feed additive filing and veterinary IVD approvals

Dossier and Safety Support

Registration dossier preparation and safety studies
Toxicology and residue coordination

Labeling & Authority Engagement

Label content review
Liaison with regulatory authorities
Industrial & Consumer Goods Regulatory Services

Industrial & Consumer Goods Regulatory Services

We deliver regulatory consulting for industrial and consumer goods, providing a flexible approach that supports global regulatory certifications and ongoing compliance.

Product Certification
& Testing

CCC, CEL, CCCF, SELO, HAF 604, RoHS, SRRC, NAL
Factory audits and performance testing

Labeling & Customs Compliance

Review of technical labels, manuals, and packaging
HS code classification and tariff advisory services

Legal Representation & Ongoing Compliance

Domestic agent services
Lifecycle management and monitoring of regulatory changes

Why Work with Cisema?

One Partner, Full Lifecycle Support

From pre-market strategy to post-market compliance, we provide support to internal regulatory teams and ensure seamless lifecycle management.

Regional Reach, Global Presence

Based in Asia and Europe with a global team delivering global reach.

Cross-Industry Expertise

Pharma, biotech, medical devices, cosmetics, supplements, veterinary, industrial and consumer goods.

Proven Results

Over 20 years of regulatory submissions, regulatory expertise, and approvals to drive business success.

Market Access Consulting

Aktuelle Einblicke

Mehr anzeigen

Hong Kong Introduces Measures for Priority Approval of Innovative Medical Devices

Updated MDACS guidance creates a new pathway for qualifying technologies and outlines the evidence required for priority consideration.

August 3, 2026
Hong Kong Introduces Measures for Priority Approval of Innovative Medical Devices

CDE Releases 2025 Annual Report on the Progress of Clinical Trials for New Drug Registration in China

Explore the latest data on China’s clinical research landscape, including record trial activity, shorter development timelines, and emerging R&D trends.

August 3, 2026
CDE Releases 2025 Annual Report on the Progress of Clinical Trials for New Drug Registration in China

China Targets 65 Drugs in Its 12th National Procurement Round

The 12th national VBP round introduces tighter quality, manufacturing, and IP requirements that pharmaceutical companies must meet to compete.

August 3, 2026
China Targets 65 Drugs in Its 12th National Procurement Round

China CDE Defines Classification Rules for Cell & Gene Therapy Drugs

New NMPA CDE guidelines define CTMP and GTMP boundaries, affecting development strategy, CMC planning, and regulatory engagement in China.

August 3, 2026
China CDE Defines Classification Rules for Cell & Gene Therapy Drugs

China's 2026 Essential Medicines Adds More Innovative Drugs

China's updated National Essential Medicines List expands access to innovative medicines, creating new opportunities and strategic considerations for pharmaceutical companies.

August 3, 2026
China's 2026 Essential Medicines Adds More Innovative Drugs
A middle-aged man with glasses is looking down thoughtfully as he pours medication or pills from a small white bottle with a yellow label into his open palm.

China NMPA Expands Priority Review for Chemical API Marketing Authorization Applications

China's NMPA expands priority review eligibility for chemical API marketing authorization applications, supporting domestic API production and drug supply.

August 3, 2026
China NMPA Expands Priority Review for Chemical API Marketing Authorization Applications
Chemical API Manufacturing
Zurück
Zurück

Engage Our Regulatory Affairs Consultants

Whether your product is pharmaceutical, cosmetic, medical, or industrial, we help you meet all regulatory obligations across China and Asia Pacific.

Angebot anfordern